Water for Injection (WFI) refers to a highly purified water used in the production of pharmaceuticals and medical devices. It is prepared according to rigorous quality standards and must meet the requirements specified by pharmacopoeial authorities. WFI should be free from impurities, such as microorganisms, endotoxins, and particles, and be suitable for parenteral administration (administered through injection). WFI is typically used in the formulation, manufacturing, and testing of pharmaceutical products, as well as for the cleaning and sterilization of equipment and packaging materials.
The global Water for Injection (WFI) market was valued at US$ 22000 million in 2023 and is anticipated to reach US$ 33710 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Water for Injection (WFI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Water for Injection (WFI).
Report Scope
The Water for Injection (WFI) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Water for Injection (WFI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Water for Injection (WFI) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Johnson and Johnson
Acella Pharmaceuticals
Merck KGaA
AdvaCare Pharma
B. Braun SE
FUJIFILM Holdings
GlaxoSmithKline
Merit Healthcare International
Novartis AG
Pfizer
Pharma Cure Laboratories
Sanofi
Zhejiang Tianrui Pharmaceutical
Zhuhai Tongyuan Pharmaceutical
Shandong Kanghua
Segment by Type
Bacteriostatic Water for Injection
Sterile Water for Injection
Segment by Application
Research Institutes
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Water for Injection (WFI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Water for Injection (WFI) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Water for Injection (WFI) Market Overview
1.1 Product Overview and Scope of Water for Injection (WFI)
1.2 Water for Injection (WFI) Segment by Type
1.2.1 Global Water for Injection (WFI) Market Value Comparison by Type (2024-2030)
1.2.2 Bacteriostatic Water for Injection
1.2.3 Sterile Water for Injection
1.3 Water for Injection (WFI) Segment by Application
1.3.1 Global Water for Injection (WFI) Market Value by Application: (2024-2030)
1.3.2 Research Institutes
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Others
1.4 Global Water for Injection (WFI) Market Size Estimates and Forecasts
1.4.1 Global Water for Injection (WFI) Revenue 2019-2030
1.4.2 Global Water for Injection (WFI) Sales 2019-2030
1.4.3 Global Water for Injection (WFI) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Water for Injection (WFI) Market Competition by Manufacturers
2.1 Global Water for Injection (WFI) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Water for Injection (WFI) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Water for Injection (WFI) Average Price by Manufacturers (2019-2024)
2.4 Global Water for Injection (WFI) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Water for Injection (WFI), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Water for Injection (WFI), Product Type & Application
2.7 Water for Injection (WFI) Market Competitive Situation and Trends
2.7.1 Water for Injection (WFI) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Water for Injection (WFI) Players Market Share by Revenue
2.7.3 Global Water for Injection (WFI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Water for Injection (WFI) Retrospective Market Scenario by Region
3.1 Global Water for Injection (WFI) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Water for Injection (WFI) Global Water for Injection (WFI) Sales by Region: 2019-2030
3.2.1 Global Water for Injection (WFI) Sales by Region: 2019-2024
3.2.2 Global Water for Injection (WFI) Sales by Region: 2025-2030
3.3 Global Water for Injection (WFI) Global Water for Injection (WFI) Revenue by Region: 2019-2030
3.3.1 Global Water for Injection (WFI) Revenue by Region: 2019-2024
3.3.2 Global Water for Injection (WFI) Revenue by Region: 2025-2030
3.4 North America Water for Injection (WFI) Market Facts & Figures by Country
3.4.1 North America Water for Injection (WFI) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Water for Injection (WFI) Sales by Country (2019-2030)
3.4.3 North America Water for Injection (WFI) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Water for Injection (WFI) Market Facts & Figures by Country
3.5.1 Europe Water for Injection (WFI) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Water for Injection (WFI) Sales by Country (2019-2030)
3.5.3 Europe Water for Injection (WFI) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Water for Injection (WFI) Market Facts & Figures by Country
3.6.1 Asia Pacific Water for Injection (WFI) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Water for Injection (WFI) Sales by Country (2019-2030)
3.6.3 Asia Pacific Water for Injection (WFI) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Water for Injection (WFI) Market Facts & Figures by Country
3.7.1 Latin America Water for Injection (WFI) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Water for Injection (WFI) Sales by Country (2019-2030)
3.7.3 Latin America Water for Injection (WFI) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Water for Injection (WFI) Market Facts & Figures by Country
3.8.1 Middle East and Africa Water for Injection (WFI) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Water for Injection (WFI) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Water for Injection (WFI) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Water for Injection (WFI) Sales by Type (2019-2030)
4.1.1 Global Water for Injection (WFI) Sales by Type (2019-2024)
4.1.2 Global Water for Injection (WFI) Sales by Type (2025-2030)
4.1.3 Global Water for Injection (WFI) Sales Market Share by Type (2019-2030)
4.2 Global Water for Injection (WFI) Revenue by Type (2019-2030)
4.2.1 Global Water for Injection (WFI) Revenue by Type (2019-2024)
4.2.2 Global Water for Injection (WFI) Revenue by Type (2025-2030)
4.2.3 Global Water for Injection (WFI) Revenue Market Share by Type (2019-2030)
4.3 Global Water for Injection (WFI) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Water for Injection (WFI) Sales by Application (2019-2030)
5.1.1 Global Water for Injection (WFI) Sales by Application (2019-2024)
5.1.2 Global Water for Injection (WFI) Sales by Application (2025-2030)
5.1.3 Global Water for Injection (WFI) Sales Market Share by Application (2019-2030)
5.2 Global Water for Injection (WFI) Revenue by Application (2019-2030)
5.2.1 Global Water for Injection (WFI) Revenue by Application (2019-2024)
5.2.2 Global Water for Injection (WFI) Revenue by Application (2025-2030)
5.2.3 Global Water for Injection (WFI) Revenue Market Share by Application (2019-2030)
5.3 Global Water for Injection (WFI) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Water for Injection (WFI) Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Description and Business Overview
6.2.3 Johnson and Johnson Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson and Johnson Water for Injection (WFI) Product Portfolio
6.2.5 Johnson and Johnson Recent Developments/Updates
6.3 Acella Pharmaceuticals
6.3.1 Acella Pharmaceuticals Corporation Information
6.3.2 Acella Pharmaceuticals Description and Business Overview
6.3.3 Acella Pharmaceuticals Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Acella Pharmaceuticals Water for Injection (WFI) Product Portfolio
6.3.5 Acella Pharmaceuticals Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Corporation Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck KGaA Water for Injection (WFI) Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 AdvaCare Pharma
6.5.1 AdvaCare Pharma Corporation Information
6.5.2 AdvaCare Pharma Description and Business Overview
6.5.3 AdvaCare Pharma Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AdvaCare Pharma Water for Injection (WFI) Product Portfolio
6.5.5 AdvaCare Pharma Recent Developments/Updates
6.6 B. Braun SE
6.6.1 B. Braun SE Corporation Information
6.6.2 B. Braun SE Description and Business Overview
6.6.3 B. Braun SE Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 B. Braun SE Water for Injection (WFI) Product Portfolio
6.6.5 B. Braun SE Recent Developments/Updates
6.7 FUJIFILM Holdings
6.6.1 FUJIFILM Holdings Corporation Information
6.6.2 FUJIFILM Holdings Description and Business Overview
6.6.3 FUJIFILM Holdings Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FUJIFILM Holdings Water for Injection (WFI) Product Portfolio
6.7.5 FUJIFILM Holdings Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Corporation Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GlaxoSmithKline Water for Injection (WFI) Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
6.9 Merit Healthcare International
6.9.1 Merit Healthcare International Corporation Information
6.9.2 Merit Healthcare International Description and Business Overview
6.9.3 Merit Healthcare International Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merit Healthcare International Water for Injection (WFI) Product Portfolio
6.9.5 Merit Healthcare International Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis AG Water for Injection (WFI) Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Water for Injection (WFI) Description and Business Overview
6.11.3 Pfizer Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Water for Injection (WFI) Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Pharma Cure Laboratories
6.12.1 Pharma Cure Laboratories Corporation Information
6.12.2 Pharma Cure Laboratories Water for Injection (WFI) Description and Business Overview
6.12.3 Pharma Cure Laboratories Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Pharma Cure Laboratories Water for Injection (WFI) Product Portfolio
6.12.5 Pharma Cure Laboratories Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Water for Injection (WFI) Description and Business Overview
6.13.3 Sanofi Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sanofi Water for Injection (WFI) Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Zhejiang Tianrui Pharmaceutical
6.14.1 Zhejiang Tianrui Pharmaceutical Corporation Information
6.14.2 Zhejiang Tianrui Pharmaceutical Water for Injection (WFI) Description and Business Overview
6.14.3 Zhejiang Tianrui Pharmaceutical Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhejiang Tianrui Pharmaceutical Water for Injection (WFI) Product Portfolio
6.14.5 Zhejiang Tianrui Pharmaceutical Recent Developments/Updates
6.15 Zhuhai Tongyuan Pharmaceutical
6.15.1 Zhuhai Tongyuan Pharmaceutical Corporation Information
6.15.2 Zhuhai Tongyuan Pharmaceutical Water for Injection (WFI) Description and Business Overview
6.15.3 Zhuhai Tongyuan Pharmaceutical Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zhuhai Tongyuan Pharmaceutical Water for Injection (WFI) Product Portfolio
6.15.5 Zhuhai Tongyuan Pharmaceutical Recent Developments/Updates
6.16 Shandong Kanghua
6.16.1 Shandong Kanghua Corporation Information
6.16.2 Shandong Kanghua Water for Injection (WFI) Description and Business Overview
6.16.3 Shandong Kanghua Water for Injection (WFI) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shandong Kanghua Water for Injection (WFI) Product Portfolio
6.16.5 Shandong Kanghua Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Water for Injection (WFI) Industry Chain Analysis
7.2 Water for Injection (WFI) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Water for Injection (WFI) Production Mode & Process
7.4 Water for Injection (WFI) Sales and Marketing
7.4.1 Water for Injection (WFI) Sales Channels
7.4.2 Water for Injection (WFI) Distributors
7.5 Water for Injection (WFI) Customers
8 Water for Injection (WFI) Market Dynamics
8.1 Water for Injection (WFI) Industry Trends
8.2 Water for Injection (WFI) Market Drivers
8.3 Water for Injection (WFI) Market Challenges
8.4 Water for Injection (WFI) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott Laboratories
Johnson and Johnson
Acella Pharmaceuticals
Merck KGaA
AdvaCare Pharma
B. Braun SE
FUJIFILM Holdings
GlaxoSmithKline
Merit Healthcare International
Novartis AG
Pfizer
Pharma Cure Laboratories
Sanofi
Zhejiang Tianrui Pharmaceutical
Zhuhai Tongyuan Pharmaceutical
Shandong Kanghua
听
听
*If Applicable.